Melatonin Vitabalans

Melatonin, the active ingredient in Melatonin Vitabalans, is a melatonin receptor agonist presented as an oral formulation for oral use. It is employed to help synchronize the body's internal clock, supporting the onset of sleep and improving sleep quality in adults experiencing insomnia, jet lag, or other circadian rhythm‑related sleep disturbances.

GNH USA supplies Melatonin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets, with reliable logistics and documentation support.

Melatonin acts on melatonin receptors to treat sleep‑related disorders.

- Insomnia: reduces sleep onset latency and improves total sleep time in adults. - Jet lag: helps adjust the circadian clock after rapid travel across time zones. - Delayed sleep phase disorder: advances sleep timing to a more conventional schedule. - Shift work disorder: mitigates sleep difficulty caused by irregular work hours. - Non‑24‑hour sleep‑wake disorder: supports alignment of the sleep‑wake cycle with the 24‑hour day.

Common Side Effects: - Headache: mild to moderate discomfort often occurring after the first dose. - Dizziness: transient sensation of light‑headedness. - Daytime sleepiness: feeling unusually drowsy during waking hours. - Nausea: mild gastrointestinal upset. - Vivid dreams: unusually intense or memorable dreaming. - Mild abdominal discomfort: occasional stomach ache.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or angioedema. - Severe hypotension: marked drop in blood pressure causing faintness. - Mood changes: depression, anxiety, or irritability. - Hallucinations: visual or auditory disturbances. - Seizures: rare occurrence of convulsive episodes. - Severe depression or suicidal thoughts: rare but serious psychiatric events.

Before using Melatonin Vitabalans, consider the following precautions: - Assess underlying conditions: evaluate for depression, seizure disorders, or severe hepatic impairment. - Age restrictions: avoid routine use in children unless specifically prescribed. - Concomitant CNS depressants: review use of sedatives or alcohol to prevent excessive sedation. - Monitor daytime sleepiness: adjust timing or dose if persistent drowsiness occurs. - Pregnancy and lactation: discuss potential risks with a healthcare professional. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and light.

Melatonin may interact with several medicines.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause excessive sedation and respiratory depression. - Anticoagulants (e.g., warfarin): melatonin may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): potential alteration of melatonin metabolism.

Moderate Interactions (Monitor Closely): - CYP1A2 inhibitors (e.g., fluvoxamine): may raise melatonin plasma levels. - CYP1A2 inducers (e.g., rifampin): may reduce melatonin effectiveness. - Alcohol: can enhance sedative effects and impair alertness.